observed an association of overweight with overall survival only in breast cancer patients with IGFBP2-positive tumors and found that IGFBP3 was correlated with BMI.21 It is possible that women with preexisting obesity are more likely to express IGFBP2. This evidence concerns the gene IGFBP2 and obesity due to melanocortin 4 receptor deficiency.